Research

Make Your Voice Heard: Join the Call to Action for PN Advocacy!

Help Advocate for Government Funding for Peripheral Neuropathy Research in 2025 Due to the Foundation for Peripheral Neuropathy’s (FPN) advocacy efforts on the Hill, and countless letters from PN patients like you, Congress designated peripheral neuropathy as a condition in the Peer Reviewed Medical Research Program (PRMRP) in the annual Defense Appropriations Act during fiscal …

Make Your Voice Heard: Join the Call to Action for PN Advocacy! Read More »

PN renewed in 2024 Defense Appropriations Bill

PN Renewed in 2024 Defense Appropriations Bill

On March 23, 2024, the Senate Committee on Appropriations approved, by a large bipartisan vote, the Senate version of the fiscal year 2024 Defense Appropriations Bill. As it has in the three previous years (FY21-23), the Committee renewed “peripheral neuropathy” (PN) as an eligible condition for receiving research grants from the Department of Defense’s Peer Reviewed …

PN Renewed in 2024 Defense Appropriations Bill Read More »

FY24 Peer Reviewed Medical Research Program

FY24 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available!

For the fourth consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $370 million fund for FY24. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) is sharing with you the FY24 funding mechanisms, award amounts, maximum direct costs and how to apply. FY24 …

FY24 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available! Read More »

Newly Funded Research: Targeting Local B Cells to Prevent Chronification of Neuropathic Pain

Principal Investigators Peter Grace, PhD, from MD Anderson Cancer Center, University of Texas, and Cobi Heijnen, PhD, from Rice University, were recently granted Investigator-Initiated Research Awards. Grace received funding totaling USD$3,064,079, and Heijnen received funding totaling USD$165,704. Peripheral Neuropathy Advocacy Grace and Heijnen’s awards were made possible through the Foundation for Peripheral Neuropathy’s (FPN) advocacy …

Newly Funded Research: Targeting Local B Cells to Prevent Chronification of Neuropathic Pain Read More »

Newly Funded Research: A Novel miR-155 Therapy for the Treatment of Peripheral Neuropathy

Principal Investigator Shailly Jariwala, MS, PhD, of the Henry M. Jackson Foundation, was recently granted a Discovery Award totaling USD$319,151 for her research on a new therapy for peripheral neuropathy. Peripheral Neuropathy Advocacy Jariwala’s award was made possible through the Foundation for Peripheral Neuropathy’s (FPN) advocacy efforts with the Department of Defense’s CDMRP program. Advocacy …

Newly Funded Research: A Novel miR-155 Therapy for the Treatment of Peripheral Neuropathy Read More »

Headshot of 2024 CRTS award recipient

Clinical Research Training Scholarship Recipient Announced

The Foundation for Peripheral Neuropathy (FPN) is pleased to announce the 2024 Clinical Research Training Scholarship (CRTS) recipient for peripheral neuropathy (PN), Francesco E. Michelassi, MD, Neuromuscular Research Fellow, Columbia University Irving Medical Center. Michelassi’s research is fully funded by FPN and will focus on chemotherapy-induced peripheral neuropathy (CIPN), by studying how a chemotherapy drug …

Clinical Research Training Scholarship Recipient Announced Read More »

New PN Biobank Research Discovery!

In November 2023, a new discovery was made about neuropathic pain in patients suffering from idiopathic peripheral neuropathy. Using data from the Peripheral Neuropathy Research Registry (PNRR), the Foundation for Peripheral Neuropathy’s research consortium completed an important analysis that led to an important discovery. This research is now published in a renowned research journal. Plasma …

New PN Biobank Research Discovery! Read More »

FPN Funds IMAGiNe Study for anti-MAG Research

Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000 of these funds were spent in 2022, which resulted in over 150 new patients enrolling in the study. In 2023, an additional $27,375 was spent, …

FPN Funds IMAGiNe Study for anti-MAG Research Read More »

TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING

Anti-MAG neuropathy refers to a rare auto-immune associated cause of peripheral neuropathy (PN). In this case, the person’s own immune system (specifically, the IgM monoclonal antibodies) attack nerve cells required for a healthy peripheral nervous system –resulting in a slowly progressive and debilitating condition. Patients often experience loss of mobility, muscle weakness, balance, numbness and …

TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING Read More »

Importance of Peripheral Neuropathy Recognized in Appropriations Act

Since 2019, the Foundation for Peripheral Neuropathy has been actively engaged in a campaign to increase federal funding for peripheral neuropathy research. We had an extraordinary breakthrough in fiscal year 2021, when Congress included “peripheral neuropathy” as an eligible condition for research funding from the Department of Defense’s Peer Reviewed Medical Research Program (PRMRP), and Congress …

Importance of Peripheral Neuropathy Recognized in Appropriations Act Read More »